2+ hour, 9+ min ago   (596+ words) The Liverpool Accelerate Laboratory will deploy AI-driven robotics alongside human organoid models to advance infectious disease research at scale. Source: Liverpool School of Tropical Medicine A new £20 million high-security robotic laboratory designed to accelerate research into deadly infections and diseases…...

21+ hour, 40+ min ago   (429+ words) OutSee has secured £50,000 through Innovate UK’s Investor Partnership Grant to pilot an agentic AI sub-system that will automate early-stage triage of drug targets generated by Nomaly, its core AI genomics platform. Genomics and drug discovery company OutSee has secured £50,000 in…...

6+ day, 20+ hour ago   (387+ words) The models were developed through Insilico’s MMAI Gym for Science framework, which trains compact language models on groups of related scientific problems rather than relying on general-purpose capabilities. Insilico said the approach is intended to address areas such as ADMET…...

1+ week, 1+ day ago   (272+ words) What if sequencing could become a unified, in-house capability across the biotherapeutic pipeline? By the end of the session, attendees will gain practical examples of how Pfizer is expanding the role of genomics across its discovery funnel and leveraging Oxford…...

1+ week, 1+ day ago   (515+ words) As new approach methodologies (NAMs) move into mainstream drug discovery, advanced models are demanding more from the assays used to measure them. Discover the six requirements for generating reliable, reproducible and biologically meaningful data. As drug development shifts towards new…...

2+ week, 2+ day ago   (340+ words) AI is accelerating drug discovery, yet attrition rates remain high. Its greatest impact may lie not in finding drugs faster, but in helping researchers understand the complex biology driving disease. If AI is making drug discovery dramatically faster, why isn’t…...

3+ week, 5+ day ago   (962+ words) Researchers have shown in mice that vaccine nanoparticles with greater avidity produce stronger, longer-lasting immune responses and give rare broadly neutralising antibody precursor B cells a competitive advantage in germinal centres, adding a new engineering variable to HIV vaccine design....

4+ week, 1+ day ago   (852+ words) Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access to technologies that were unimaginable mere decades…...

4+ week, 1+ day ago   (367+ words) A preclinical study published ha demonstrated how AI-assisted screening can unlock challenging cancer targets, with Mayo Clinic researchers identifying a GIPC1 inhibitor that slows tumour growth and potentiates gemcitabine activity in pancreatic cancer models. Researchers at Mayo Clinic have used artificial…...

4+ week, 1+ day ago   (436+ words) Insilico Medicine has nominated an artificial intelligence-designed drug candidate for the potential treatment of several inflammatory and degenerative eye diseases including dry age-related macular degeneration (dry AMD), uveitis and dry eye disease. The company said ISM9077 had been selected as a…...